The interplay between NOD2 and TLR2 following recognition of components of the bacterial cell wall peptidoglycan is well established, however their role in redirecting metabolic pathways in myeloid cells to degrade pathogens and mount antigen presentation remains unclear. We show NOD2 and TLR2 mediate phosphorylation of the deubiquitinase ataxin-3 via RIPK2 and TBK1. In myeloid cells ataxin-3 associates with the mitochondrial cristae protein MIC60, and is required for oxidative phosphorylation. Depletion of ataxin-3 leads to impaired induction of mitochondrial reactive oxygen species (mROS) and defective bacterial killing. A mass spectrometry analysis of NOD2/TLR2 triggered ataxin-3 deubiquitination targets revealed immunometabolic regulators, including HIF-1α and LAMTOR1 that may contribute to these effects. Thus, we define how ataxin-3 plays an essential role in NOD2 and TLR2 sensing and effector functions in myeloid cells.
Introduction
Pattern recognition receptors (PRRs) recognize foreign antigen to direct innate and adaptive immune responses against invading pathogens (1) . Polymorphisms in the PRR nucleotide-binding oligomerization domain-containing protein 2 (NOD2) represent the strongest genetic risk factor for the inflammatory bowel disease Crohn's (CD), and thus this bacterial sensor is the focus of particular research interest (2) (3) (4) . NOD2 recognizes muramyl dipeptide (MDP), the largest fraction of peptidoglycan, that is present in the cell walls of all bacteria (5) . Subsequent activation of NF-κB and MAPK pathways via interaction with receptor-interacting protein kinase 2 (RIPK2) results in an array of immune responses such as production and regulation of pro-inflammatory cytokines (6) , and modulation of T-cell function (7) (8) (9) . NOD2 also directs autophagy, which is important both for bacterial clearance and MHC class II antigen presentation (10) . Importantly, NOD2 signaling is intimately linked with that of toll like receptor TLR2, with both responding to ligands derived from the same bacterial component, peptidoglycan. Although the precise mechanisms of cross-regulation are not well understood, both NOD2 and TLR2 activate separate upstream signaling cascades to recruit the same NF-κΒ and MAPK pathways, and are typically thought to act in a synergistic fashion (11) . CD patients harboring NOD2 polymorphisms display loss-of-function for induction of NOD2 and NOD2/TLR2 effector signaling factors (12, 13) .
In contrast, gain-of-function mutations of NOD2 have been associated with other inflammatory disease such as
Blau syndrome and early-onset-sarcoidosis (EOS).
In recent years it has become clear that cross-talk between metabolic and immune pathways is central to the regulation of host defence (14) . Immune cells undergo significant metabolic reprogramming during the immune response, both as a result of changes in the metabolic microenvironment induced by inflammation, and in response to immune triggering. This interplay appears of particular importance to dendritic cells and macrophages and controls core processes including differentiation (15) . However, while the importance of PRR activation in directing metabolic pathways that impact on immune effector function is now well established, how NOD2 and TLR2 influence myeloid metabolism is unclear. Here, following a phosphoproteomic screen of NOD2 and TLR signaling we identify a deubiquitinase essential for metabolic reprogramming and innate effector function in myeloid cells.
Results

NOD2 and TLR2 stimulation leads to ataxin-3 phosphorylation mediated by
RIPK2 and TBK1
We identified ataxin-3 as one of the most differentially phosphorylated proteins on NOD2/TLR2 stimulation through a quantitative phosphoproteomic screen in monocyte derived dendritic cells (moDCs) from healthy human donors (Supplementary table 1 ). Ataxin-3 is a deubiquitinase (DUB) (16) that is required for non-selective autophagy and that is linked to neurodegenerative disease (17) (18) (19) .
We first validated this result by immunoblotting phospho-enriched samples for ataxin-3 ( Figure 1A ). Both NOD2 and TLR2 stimulation alone led to ataxin-3 phosphorylation; this effect was enhanced on dual stimulation of NOD2 and TLR2. It was also observed to a lesser extent following stimulation of TLR4, TLR7 and TLR8
( Figure 1A ). NOD2 mediated phosphorylation of Ataxin-3 was examined in greater detail. A time course experiment demonstrated that ataxin-3 phosphorylation was maximal 30 minutes after MDP stimulation ( Figure 1B ). While NOD2 is the only known receptor for MDP, the absolute requirement for NOD2 in the MDP stimulated phosphorylation of ataxin-3 was investigated. We downregulated expression of NOD2 in THP-1 cells using short hairpin RNAs (shRNA) targeting NOD2 ( Figure 1C ).
Reduction of ataxin-3 phosphorylation on MDP exposure was observed in NOD2 knockdown cells ( Figure 1D ). Next, given the central importance of RIPK2 in NOD2
signaling (20, 21) , the requirement of RIPK2 for phosphorylation of ataxin-3 by NOD2 was investigated. NOD2-RIPK2 inflammatory signalling can be potently and selectively inhibited by the clinically relevant kinase inhibitor Ponatinib, that functions by blocking RIPK2 autophosphorylation and ubiquitination (22) . moDCs were treated with Ponatinib prior to stimulation with MDP or PAM 3 CSK 4 or both, with phosphorylation of p38 used as a positive control for the inhibitor. As expected, inhibition of RIPK2 blocked NOD2 induced phosphorylation of p38, but had no effect on induction by TLR2, which signals to p38 via a MyD88 pathway which is independent of RIPK2 (23) . Inhibition of RIPK2 led to complete inhibition of NOD2
induced phosphorylation of ataxin-3, and significant abrogation of the synergistic NOD2/TLR2 signal in both cell types ( Figure 1E ). Recent evidence suggests that tank binding kinase 1 (TBK1) may represent a novel but important kinase in the NOD2/RIPK2 signalling cascade (24, 25) and MDP stimulation of the NOD2 receptor has been shown to induce TBK1 phosphorylation at S172 (24) . Consequently, the requirement for TBK1 in NOD2/RIPK2 dependent phosphorylation of ataxin-3 was examined. We downregulated expression of TBK1 in THP-1 cells using short hairpin RNAs (shRNA) targeting NOD2 ( Figure 1F ). Reduction of ataxin-3 phosphorylation on MDP exposure was observed in TBK1 knockdown cells ( Figure 1G ). The possibility that TBK1 might directly phosphorylate ataxin-3, as has been described for a number of other proteins including optineurin (26) and p62 (27) , was explored using an in vitro kinase assay ( Figure 1H ). The expected autophosphorylation of TBK1 was demonstrated by a marginally higher molecular weight of the TBK1 band in samples containing both TBK1 and ATP. Importantly, a significant proportion of the ataxin-3 band was noted at a higher molecular weight in samples containing ataxin-3, TBK1 and ATP, consistent with ataxin-3 phosphorylation ( Figure 1H ).
Notably, no change in migration of the ataxin-3 band was seen in samples containing ataxin-3 and TBK1 but not ATP, confirming the ATP dependency of this shift, consistent with phosphorylation. Finally, the phosphorylation site of ataxin-3 was sought, using liquid chromatography mass spectrometry analysis of endogenous ataxin-3 immunoprecipitated from THP-1 cells. A significant shift in mass/charge ratio, consistent with phosphorylation, was detected at a single peptide in the MDP/PAM 3 CSK 4 stimulated sample only, corresponding to phosphorylation at serine 265 ( Figure 1I ). This residue has been described as a phosphorylation site in 12 separate large scale mass spectrometry (MS) screens of human primary cells and cell lines (28) , and is highly conserved in placental bearing mammals (29) , but there is no existing knowledge of its functional relevance. It is located in close proximity to the second ubiquitin interacting motif (UIM), suggesting that phosphorylation could affect specificity of DUB target, as has been described for neighbouring serine residues 256/260/261 (30) ( Figure 1J ).
Taken together, this data shows that activation of NOD2/TLR2 signaling pathway induces phosphorylation of the DUB ataxin-3. TBK1 is required for the direct phosphorylation of ataxin-3 at serine 265 following NOD2/TLR2 activation.
Ataxin-3 localizes with the mitochondrial cristae protein MIC60 and regulates the expression of the oxphos machinery components
To identify novel interacting partners of ataxin-3 in innate immune cells, endogenous ataxin-3 was immunoprecipitated in moDCs from healthy human donors and subjected to mass spectrometry analysis. One of the most abundant proteins identified in the pull down was the mitochondrial cristae protein MIC60 (Figure 2 A,   B ). The association between ataxin-3 and MIC60 was validated through immunoblot of immunoprecipitated ataxin-3 ( Figure 2C ). There appeared to be no change in abundance of MIC60 when moDCs were stimulated with MDP + PAM 3 CSK 4 prior to immunoprecipitation of ataxin-3, suggesting that NOD2/TLR2 stimulation does not affect binding. To further confirm the association, MIC60 was pulled down, and an immunoblot for ataxin-3 performed ( Figure 2D ). Here, ataxin-3 appeared at two molecular weights, suggesting that either two separate isoforms bind to MIC60, or it is post-translationally modified. Finally, super-resolution assessment using stimulated emission depletion (STED) microscopy confirmed that ataxin-3 was situated in close proximity to MIC60 ( Figure 2E ).
MIC60 is the largest protein in the mitochondrial contact site (MICOS) complex, which is embedded in the mitochondrial inner membrane and acts as a key regulator of cristae junction formation and assembly of respiratory chain complexes which are required for oxidative phosphorylation (31) . Additional specific roles for MIC60
include the import of proteins (32, 33) and regulation of mitochondrial DNA (mtDNA) transcription (34, 35) . Consequently, we examined the effect of ataxin-3 knockdown in moDCS on expression of mtDNA genes that encode components of the oxphos machinery. moDCS from healthy human donors were found to express either a single or double isoform of ataxin-3 with approximately equal frequency, but all detectable isoforms could be efficiently knocked down ( Figure 2F ). Ataxin-3 depletion led to a two-fold upregulation of NADH-ubiquinone oxidoreductase 1 (MT-ND1), with a statistically significant upregulation observed for mRNA expression of two other genes from Complex I, MT-ND3 and MT-ND4L ( Figure 2G ). In comparison, genes encoding components of Complex II, III and IV were broadly unaffected. It is noteworthy that mtDNA transcription is tightly regulated due to its close links to oxphos, and thus 1.5 to 2 fold changes in mRNA expression level represent a potentially functionally significant alteration (36) . The effect of NOD2/TLR2 stimulation was examined on MT-ND1, the most significantly affected gene. Stimulation led to a significant upregulation in mRNA expression in both the control and ataxin-3 depleted cells, but there was significantly greater ND1 in the ataxin-3 depleted cells following stimulation ( Figure 2H ).
These results indicate a novel association between ataxin-3 and MIC60, a component of the MICOS complex involved in the regulation of mtDNA. We demonstrated that ataxin-3 regulates mtDNA by downregulating the expression of Complex I genes, an effect increased on NOD2/TLR2 sensing.
Ataxin-3 is important for optimal mitochondrial respiration following NOD2 and
TLR2 stimulation
We next investigated the functional relevance of the observed changes in the expression of Complex I genes. Using short hairpin RNAs (shRNA) targeting ataxin-3, we downregulated ataxin-3 expression in THP-1 cells (Figure 3a) . We next performed a real time analysis of oxidative phosphorylation to address the function of Ataxin-3. We found that Ataxin-3 depletion led to a significant reduction in all the key parameters of mitochondrial respiration assessed ( Figure 3B -F).
We next determined whether NOD2/TLR2-mediated ataxin-3 phosphorylation stimulation affects mitochondrial respiration. Prolonged triggering of these PRRs led to an expected metabolic shift (37) with downregulation of oxidative phosphorylation.
In the ataxin-3 depleted cells the level of oxphos remained significantly lower than in the control cells following stimulation ( Figure 3G -J). Importantly, no significant difference in mtDNA copy number was found between the control and ataxin-3 depleted THP-1 cell line (Supplementary figure 1) , suggesting that there are no differences in mitochondrial mass or turnover through mitophagy to explain the observed changes.
Taken together, this data shows that in innate immune cells, ataxin-3 is required for optimal mitochondrial respiration and this effect is enhanced following its phosphorylation on NOD2/TLR2 stimulation.
Ataxin-3 is required for mitochondrial ROS production, and is necessary for optimal bacterial killing.
A key function of mitochondrial respiration in immune cells is the generation of mROS. This results from leakage of electrons, predominantly from Complex I and to a lesser extent from Complex III, which partially reduce oxygen to form superoxide (38) . The effect of ataxin-3 depletion on mROS and total cellular ROS was therefore examined. Ataxin-3 depletion led to a significant reduction in mROS ( Figure 4A ). As expected, there was a corresponding decrease in total cellular ROS, to which mROS makes a significant contribution ( Figure 4B ). The ability of immune cells to upregulate mROS production on pathogen challenge is crucial to the immune response (39); importantly, ataxin-3 depleted cells also produced less mROS on NOD2/TLR2 stimulation ( Figure 4C ). mROS forms an important component of antibacterial responses, and is important for bacterial killing (39) . To test the functional significance of the observed impairment of mitochondrial oxphos and mROS generation on NOD2/TLR2 triggering, we assessed the response of ataxin-3 depleted macrophages to Salmonella typhimurium, a Gram-negative intracellular bacterium that is sensitive to ROS-dependent killing (39, 40) . A gentamicin survival assay was undertaken. While bacterial invasion was unchanged, as evidenced by similar bacterial counts at one hour post infection, there was subsequently significantly greater bacterial survival in the ataxin-3 depleted cells that was maximal at six hours ( Figure 4D ). There were no significant differences in cell viability between the two groups at any of the infection time points (Supplementary figure 2), excluding differences in cell survival as a contributing factor in the bacterial killing deficit.
Taken together, this data shows that in macrophages ataxin-3 is required for mROS generation and this contributes to effective intracellular bacterial killing.
An unbiased ubiquitome screen reveals novel DUB targets of ataxin-3 following NOD2 and TLR2 activation
To further define the role of ataxin-3 in NOD2/TLR2 signaling, we sought to define downstream DUB targets. Classically the ubiquitinated proteome, also termed the ubiquitome, was first enriched using His 6 -tagged ubiquitinated conjugates under denaturing conditions. However, concerns exist over the impact of overexpressed modified His 6, which competes with endogenous ubiquitin, on the ubiquitome (41).
An alternative method of enrichment, using high affinity ubiquitin traps has therefore been developed. Figure 5B ).
Mass spectrometry analysis identified 291 proteins as changing significantly between any condition when averaged across the three biological replicates. As ataxin-3 acts as a DUB, ataxin-3 depletion would classically lead to an accumulation of ubiquitinated targets and thus particular attention was paid to those proteins that showed an increase in abundance in the ataxin-3 depleted samples (table 2) .
However, as deubiquitination can also regulate protein stability, it is likely that a number of the proteins found to decrease in abundance on ataxin-3 depletion are also direct DUB targets of ataxin-3. Most notably, the immunometabolic regulator HIF1α (45) was found to be more abundant in the ataxin-3 depleted cells, suggesting that ataxin-3 may deubiquitinate HIF1α ( Figure 5C ). To specifically interrogate the importance of NOD2/TLR2 phosphorylation of ataxin-3 on DUB activity, the abundance of proteins in the ataxin-3 depleted cells was compared to the control cells following stimulation with MDP+PAM 3 CSK 4 (Supplementary table 3) . Strikingly, a cluster of proteins related to metabolism were noted in the ataxin-3 depleted cells (marked in red on Figure 5D ). (54), but has also been linked to independent roles in lysosomal maturation (55) and M2 macrophage differentiation (56) . PLD3 and LAMTOR1 were both validated by immunoblot ( Figure 6B and C).
Ataxin-3 depletion led to accumulation of ubiquitinated forms of both PLD3 and LAMTOR1. Notably, NOD2/TLR2 stimulation increased LAMTOR1 ubiquitination in the control cells, but there was markedly more LAMTOR1 ubiquitination in the stimulated ataxin-3 depleted cells ( Figure 6C ). This suggests that ataxin-3
modulates the ubiquitination of LAMTOR1 induced by NOD2/TLR2 stimulation.
To further study the interaction between LAMTOR1 and ataxin-3, an overexpression system was employed in the human cell line HEK293. HA-ataxin-3 and GFP-LAMTOR1 was overexpressed, together with a GFP-control and then IP of HAataxin-3 performed using an antibody against the HA tag. Ataxin-3 was found to bind directly to LAMTOR1 ( Figure 6D ). Next, the finding that LAMTOR1 is a direct DUB target of ataxin-3 was confirmed. Ubiquitin, GFP-LAMTOR1 and HA-ataxin-3
were overexpressed in HEK293 cells and IP of GFP-LAMTOR1 performed using an antibody against the GFP tag. The level of ubiquitinated GFP-LAMTOR1 was found to be significantly less in cells where HA-ataxin-3 was co-expressed ( Figure 5E ).
Taken together, these results show that ataxin-3 modulates the ubiquitination of previously unidentified targets related to metabolism. This effect is enhanced on following phosphorylation of ataxin-3 on NOD2/TLR2 triggering.
Discussion
In this study we demonstrate that NOD2 and TLR2 phosphorylates the MIC60 forms a core part of the MICOS complex, which is embedded in the mitochondrial inner membrane. It acts as a key regulator of mitochondrial inner membrane shape and organisation. This is essential for cristae junction formation and assembly of respiratory chain complexes which are required for oxidative phosphorylation (31) . MIC60 also appears to act independently of the MICOS complex, and has recently been implicated in regulation of mtDNA transcription (35) . Fewer than 100 DUBs are thought to be responsible for regulating the ubiquitination of tens of thousands of proteins in a tightly regulated and sophisticated manner (57, 74) . Hence defining the wide-ranging DUB targets of ataxin-3 is essential to decipher its functions. Ubiquitin signalling represents an indispensable mechanism of regulating both the innate and adaptive immune response, and is central to the NOD2 cascade (75) . For the first time, this study undertook an unbiased screen of the ubiquitome in ataxin-3 depleted cells. Notably, a significant number of metabolism related proteins were found, further reinforcing the potential importance of ataxin-3 in cellular immunometabolism.
The discovery that HIF1α is a DUB target of ataxin-3 in macrophages is noteworthy,
given the emergency of HIF1α as a key immunometabolic regulator. Work in a conditional HIF1 α knockout mouse, targeting the myeloid lineage, demonstrated the critical requirement of HIF1 α for inflammatory responses (76) . This correlated with defects in glycolysis and metabolic activation, which is tightly regulated by HIF1 α
The endolysosomal protein PLD3 was also validated as a further novel DUB target of ataxin-3. Although PLD3 contains two phosphodiesterase domains, and hence is classed as a member of the phospholipase diesterase (PLD) family which act to hydrolyse phospholipids, the phospholipase activity of PLD3 has not been definitively The discovery in the present study that NOD2/TLR2 triggering leads to deubiquitination of LAMTOR1 by ataxin-3 is of particular interest. LAMTOR1, also known as p18, is a late endosome/lysosome membrane adapter protein that localises to the lipid rafts of these organelles (77, 78) . LAMTOR1 plays an essential role in the activation of the mTORC kinase complex in response to amino acid levels The physiological importance of NOD2 and TLR2 in both the innate and adaptive immune response is well established. The interplay between NOD2 and TLR2 has been well characterized given the fact that they both respond to adjacent components of PGN found in the bacterial cell walls. The NOD2 signaling pathway amplifies TLR2 activation and both receptors synergize in the induction of cytokine production. NOD2 variants confer the greatest single genetic risk factor for Crohn's disease disease (2, 3), yet significant gaps remain in our knowledge of how this receptor exerts its effects (83) . Notably, despite the recent explosion of interest in the field of immunometabolism, almost nothing is known about how the synergistic effects of NOD2 and TLR2 signaling might intersect with metabolic pathways to modulate the immune response. Here, we defined the molecular and functional basis by which NOD2/TLR2 sensing links to ataxin-3 and, consequently, other immunometabolic factors. Future studies are required to provide novel prospects for modulating these pathways as new therapeutic strategies for inflammatory disorders.
Materials and Methods
Cells
Human monocytes were purified from healthy donor peripheral blood mononuclear 
Reagents and antibodies
The following stains were used: MItosox Red M36008 (Invitrogen) and DHR 123 
Tandem Ubiquitin Binding Entities (TUBEs) Ubiquitin Immunoprecipitation
Liquid chromatography tandem mass spectrometry (LC-MS/MS)
100µl of lysate was adjusted to 175µl with ddH 2 0. All samples were then successively reduced and alkylated for 30 minutes with 5mM dithiothreitol and 20mM
iodoacetamide, respectively. The proteins were then precipitated using chloroformmethanol precipitation and the pellet were solubilized in 6M urea, 0.1M Tris pH 7.8.
The sample were diluted to 1M Urea. The digestion was performed overnight at 37°C by adding 500ng of trypsin. The peptides were desalted using a C18 cartridge Peptides were analysed with nano ultra-high performance liquid chromatography tandem mass spectrometry (nano-UPLC-MS/MS) using a Dionex Ultimate 3000 nanoUPLC, coupled to an Orbitrap Fusion Lumos mass spectrometer (Thermo Scientific). MS analysis was performed essentially as described previously (84) . In brief, the data were acquired with a resolution of 120,000 full-width half maximum at 
Analysis of mass spectrometry data
Label-free quantitative analysis
The raw MS data were analysed using Progenesis QI (Waters) and searched using 
Peaks search for phosphorylation
The raw data was analysed in PEAKS Studio 7.5 (Bioinformatics Solutions Inc). The settings were the following: The database used was the swissprot human database was used for the proteins identification. The enzyme used for the search was trypsin allowing a maximum of 2 miscleavages. 
Mascot search for phosphorylation
The raw data was searched using Mascot with following settings. Enzyme: Trypsin; 
Adherent cell transfection
Human HEK293/NOD2 Cells were seeded 24 hours prior to transfection in media without antibiotics. Transfection mixes were made, comprising Fugene (Promega) at a ratio of 3:1 to amount of DNA plasmid to be transfected, in the appropriate volume of Opti-MEM (Gibco, Thermo Fisher) (10% of volume of media in wells to be transfected). The transfection mixes were incubated at room temperature for 20 minutes and then added dropwise to the wells to be transfected. Cells were either cultured for a further 24 or 48 hours before being used for downstream applications.
RNA isolation
Typically 2-5 x 10 6 cells per condition were harvested and washed once with cold PBS. Pellets were resuspended in 350µl RLT buffer (Qiagen) containing 1% (v/v)
Mercapto-ethanol (Sigma) and stored at -80 o C. Samples were thawed on ice and homogenized by adding to Qiashredder columns (Qiagen) and centrifuged 2 minutes 13000rpm. RNA isolation was then peformed using RNeasy kits (Qiagen) according to manufacturer's instructions. The isolated RNA was eluted by added 25ml nuclease free water (Ambion) to the RNeasy column membrane for 5 minutes, followed by centrifugation into fresh Eppendorfs 8000g 1 minute. RNA concentration and purity were obtained using a Nanodrop 1000 spectrophotometer (Thermo Fisher) and samples were stored at -20 o C until further analysis.
Reverse Transcription
RNA was reverse transcribed using a high capacity RNA to cDNA kit (Applied Biosystems). 500ng to 2µg of RNA was normalized to the same concentration for each sample using nuclease free water (Ambion) in polypropylene PCR tubes (Starlab). Then an RT mix containing 2µl 10x RT buffer, 0.8µl 25x dNTP mix, 2µl RT random primers, 1µl multiscribe RT, 1µl RNase inhibitor (Applied Biosystems) and 3.2µl nuclease free water was added to each PCR tube (10µl total RT mix) (Starlab) for a total volume of RNA sample and RT mix of 20µl. This was reverse transcribed Ct . This is derived from:
ΔΔCT=ΔCT(target condition)-CT(control condition)
Flow cytometry
Typically 0.5x10 6 THP-1 cells per condition were plated in 1ml of media in 12 well plates and differentiated for 16 hours with 25ng/ml PMA (Sigma). Following differentiation, the indicated treatments were applied. Cells were then harvested with gentle scraping and transferred to a FACS tube. The following staining protocols were then followed. Cytofluorometric evaluation was by the LSRII flow cytometer (BD Biosciences) with analysis of the data by FLOWJo.
MitoSOX Red staining
The cells were pelleted by centrigugation and resuspended in room temperature (E) Immunoblot using antibodies against ubiquitin, GFP, ataxin-3 and β−actin in input and isotype control (iso) or GFP immunoprecipitated lysates where ubiquitin and GFP-LAMTOR1
were overexpressed with or without HA-ataxin-3. 
